When we talk about a GLP-1 probiotic, we are usually looking for clinically backed probiotic strains that offer dual action support: helping with digestion and metabolic health
However, weight-loss drugs are included in a small group of drugs that can be excluded from coverage 1 (though the statutory exception refers to agents used for weight loss, obesity drugs is used to refer to this group of medications in this analysis)
You might already recognize some of the brand names in this class, including Ozempic, Wegovy, Mounjaro, and Rybelsus
By logging things consistently, patterns become clear
Patients also stop because of cost, loss of insurance, or side effects
GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: State of the art